Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1861 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

The financialisation of Big Pharma

By: MattB
Views: 1321

Accountable Care Organizations and Patient-Centered Medical Homes

By: MattB
Views: 1810

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.5

By: MattB
Views: 1956

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

By: MattB
Views: 1540

Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech

By: MattB
Views: 1277

Biopharma Companies Join Forces to Fight COVID-19

By: docshare
Views: 1489

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 3

By: MattB
Views: 1439

Granulation

By: ahaskk
Views: 1343

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

By: MattB
Views: 1861

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

By: MattB
Views: 1304

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z